IMTX
NASDAQ · Biotechnology
Immatics Nv
$6.18
-0.73 (-10.56%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,150.0% upside
Low Target
$52.47
Average Target
$77.25
High Target
$103.74
Current Price
$6.18
Current
$6.18
$6.18
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Scenario Analysis
Bear Case
$52.47
749.0%
Low target
Base Case
$77.25
+1,150.0%
Avg target
Bull Case
$103.74
+1,578.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.41
-50.2% from high
52-Week Low
$6.65
+-7.1% from low
Target vs 52W High
$77.25
+522.5% vs high
Next Earnings Report
Nov 16, 2026
9d
until earnings
EPS Est: $-0.48
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |